MiMedx Group, Inc. (MDXG) Financial Analysis & Valuation | Quarter Chart
MiMedx Group, Inc. (MDXG)
MDXGPrice: $4.94
Fair Value: 🔒
🔒score
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory... more
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healt... more
Description
Shares
| Market Cap | $731.62M | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Biotechnology |
| Country | US | CEO | Joseph H. Capper |
| IPO Date | 2008-02-12 | CAGR | — |
| Employees | 837 | Website | www.mimedx.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | 0.76% | Total Yield | 0.76% |
MDXG chart loading...
Fundamentals
Technicals
| Enterprise Value | $835.94M | P/E Ratio | 19.26 |
| Forward P/E | 15.22 | PEG Ratio | 0.12 |
| P/S Ratio | 1.75 | P/B Ratio | 2.85 |
| P/CF Ratio | 9.87 | P/FCF Ratio | 10.55 |
| EPS | $0.27 | EPS Growth 1Y | 13.39% |
| EPS Growth 3Y | -220.91% | EPS Growth 5Y | -171.6% |
| Revenue Growth 1Y | 19.99% | Gross Margin | 0.83% |
| Operating Margin | 0.15% | Profit Margin | 0.12% |
| ROE | 0.21% | ROA | 0.14% |
| ROCE | 0.23% | Current Ratio | 4.32 |
| Quick Ratio | 3.92 | Cash Ratio | 2.58 |
| Debt/Equity | 0.01 | Interest Coverage | 24.18 |
| Altman Z Score | 7.87 | Piotroski Score | 7 |